Fulgent Genetics (FLGT) Non-Current Debt (2021 - 2026)

Fulgent Genetics has reported Non-Current Debt for 6 years, with the latest figure at $1.5 million in Q2 2026.

• Quarterly Non-Current Debt fell 24.62% year-over-year to $1.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 million (down 24.62% YoY) and the FY2025 annual result came in at $2.0 million, down 21.46% from the prior year.
• Non-Current Debt held at $1.5 million in Q2 2026 per FLGT's latest filing, from $1.5 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $5.6 million in Q1 2022 and troughed at $1.5 million in Q1 2026.
• A 5-year average of $3.1 million and a median of $2.5 million in 2024 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt fell 7.14% in 2023, then slumped 52.06% in 2024.
• Over 5 years, Non-Current Debt stood at $3.4 million in 2022, then declined by 12.1% to $3.0 million in 2023, then dropped by 15.89% to $2.5 million in 2024, then dropped by 21.46% to $2.0 million in 2025, then retreated by 24.62% to $1.5 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $1.5 million, $1.5 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.